The Journal of Thoracic and Cardiovascular Surgery
Volume 139, Issue 3 , Pages 621-627 , March 2010

Preoperative very short-term, high-dose erythropoietin administration diminishes blood transfusion rate in off-pump coronary artery bypass: A randomized blind controlled study

Received 30 April 2009 ,Revised 9 September 2009 ,Accepted 4 October 2009.

References 

  1. Koch CG, Li L, Van Wagoner DR, Duncan AI, Gillinov AM, Blackstone EH. Red cell transfusion is associated with an increased risk for postoperative atrial fibrillation. Ann Thorac Surg. 2006;82:1747–1756
  2. Koch CG, Khandwala F, Li L, Estafanous FG, Loop FD, Blackstone EH. Persistent effect of red cell transfusion on health-related quality of life after cardiac surgery. Ann Thorac Surg. 2006;82:13–20
  3. Koch CG, Li L, Duncan AI, et al. Transfusion in coronary artery bypass grafting is associated with reduced long-term survival. Ann Thorac Surg. 2006;81:1650–1657
  4. Alghamdi A, Albanna M, Guru V, Brister S. Does the use of erythropoietin reduce the risk of exposure to allogeneic blood transfusion in cardiac surgery? A systematic review and meta-analysis. J Card Surg. 2006;21:320–326
  5. Paschos N, Lykissas M, Beris A. The role of erythropoietin as an inhibitor of tissue ischemia. Int J Biol Sci. 2008;4:161–168
  6. Monk TG. Preoperative recombinant human erythropoietin in anemic surgical patients. Crit Care. 2004;8(Suppl 2):45–48
  7. Goldberg MA. Perioperative epoetin alfa increases red blood cell mass and reduces exposure to transfusions: results of randomized clinical trials. Semin Hematol. 1997;34(Suppl 2):41–47
  8. YazicioGlu L, Eryilmaz S, Sirlak M, et al. Recombinant human erythropoietin administration in cardiac surgery. J Thorac Cardiovasc Surg. 2001;122:741–745
  9. Ascione R, Williams S, Lloyd C, Sundaramoorthi T, Pitsis A, Angelini G. Reduced postoperative blood loss and transfusion requirement after beating-heart coronary operations: a prospective randomized study. J Thorac Cardiovasc Surg. 2001;121:689–696
  10. Madi-Jebara SN, Sleilaty GS, Achouh PE, et al. Postoperative intravenous iron used alone or in combination with low-dose erythropoietin is not effective for correction of anemia after cardiac surgery. J Cardiothorac Vasc Anesth. 2004;18:59–63
  11. Osaka M, Fukuda I, Ohuchi H. Aprotinin and recombinant human erythropoietin reduce the need for homologous blood transfusion in cardiac surgery. Jpn J Thorac Cardiovasc Surg. 1998;46:846–853
  12. Yoshikawa Y, Niwaya K, Hasegawa J, et al. Effect of blood conservation in open-heart surgery: a comparison of 3 different methods. Kyobu Geka. 1994;47:1059–1062
  13. Price S, Pepper JR, Jaggar SI. Recombinant human erythropoietin use in a critically ill Jehovah's Witness after cardiac surgery. Anesth Analg. 2005;101:325–327
  14. Sonzogni V, Crupi G, Poma R, et al. Erythropoietin therapy and preoperative autologous blood donation in children undergoing open heart surgery. Br J Anaesth. 2001;87:429–434
  15. Shimpo H, Mizumoto T, Onoda K, Yuasa H, Yada I. Erythropoietin in pediatric cardiac surgery: clinical efficacy and effective dose. Chest. 1997;111:1565–1570
  16. Fisher JW. Pharmacologic modulation of erythropoietin production. Ann Rev Pharmacol Toxicol. 1988;28:101–122
  17. Means RT. Clinical application of recombinant erythropoietin in the anemia of chronic disease. Hematol Oncol Clin North Am. 1994;8:933–944
  18. Coyle D, Lee KM, Fergusson DA, et al. Cost effectiveness of epoetin-alpha to augment reoperative autologous blood donation in elective cardiac surgery. Pharmacoeconomics. 2000;18:161–171
  19. Marchetti M, Barosi G. Cost-effectiveness of epoetin and autologous blood donation in reducing allogeneic blood transfusions in coronary artery bypass graft surgery. Transfusion. 2000;40:673–681
  20. D'Ambra MN, Gray RJ, Hillman R, et al. Effect of recombinant human erythropoietin on transfusion risk in coronary bypass patients. Ann Thorac Surg. 1997;64:1686–1693
  21. Hayashi J, Kumon K, Takanashi S, et al. Subcutaneous administration of recombinant human erythropoietin before cardiac surgery: a double-blind, multicenter trial in Japan. Transfusion. 1994;34:142–146
  22. Crosby E. Perioperative use of erythropoietin. Am J Ther. 2002;9:371–376

 Disclosures: None.

PII: S0022-5223(09)01336-1

doi: 10.1016/j.jtcvs.2009.10.012

The Journal of Thoracic and Cardiovascular Surgery
Volume 139, Issue 3 , Pages 621-627 , March 2010

Article Tools

* Image Usage & Resolution